POMDOCTOR Limited Prices IPO on Nasdaq

October 08, 2025
POMDOCTOR Limited, a leading online medical services platform in China, has announced the pricing of its initial public offering on Nasdaq, aiming to raise approximately $20 million.

POMDOCTOR Limited, a prominent online medical services platform for chronic diseases in China, has announced the pricing of its initial public offering (IPO) of 5,000,004 American Depositary Shares (ADSs) at $4.00 per ADS. Announced in a press release, the ADSs are set to commence trading on the Nasdaq Global Market under the ticker symbol "POM" on October 8, 2025.

The company expects to generate approximately $20 million in gross proceeds from the offering, excluding underwriting discounts and related expenses. Additionally, POMDOCTOR has granted underwriters an option to purchase up to 750,000 additional ADSs within 45 days at the public offering price, less underwriting discounts.

Joseph Stone Capital, LLC is acting as the underwriter for this offering, which is being conducted on a firm commitment basis. The offering is anticipated to close on or about October 9, 2025, pending customary closing conditions.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

10/08
BD and Opentrons Collaborate on Robotic Automation for Single-Cell Multiomics
10/08
TransCelerate Advances Digital Protocols in Clinical Trials
10/07
InsightRX Achieves High Performance Score in KLAS Spotlight
10/07
Qualtrics to Acquire Press Ganey Forsta for $6.75 Billion
10/06
AstraZeneca and Algen Biotechnologies Partner for AI-Driven Gene-Editing Therapies

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like